Treatment of bronchopulmonary dysplasia. A review.
Bronchopulmonary dysplasia (BPD), first described in 1966, remains an issue of both clinical and public health importance. BPD may be associated with chronic respiratory difficulties, prolonged and recurrent hospitalization, an increased incidence of neurodevelopmental disabilities, growth restriction, and death. Controversies regarding the cause of BPD are important to resolve in an attempt to develop strategies for prevention.